About this trial
Surgical site infection (SSI) is one of the most common postoperative complications following elective laparotomy and contributes significantly to patient morbidity, prolonged hospital stay, and increased healthcare costs. Various techniques are available for skin closure, including skin staples and polypropylene sutures; however, evidence regarding their comparative effectiveness remains inconsistent, particularly in low- and middle-income countries.
This randomized controlled trial aims to compare skin staples with polypropylene sutures for skin closure following elective laparotomy. Eligible adult patients undergoing elective laparotomy at the Department of General Surgery, Pakistan Institute of Medical Sciences (PIMS), Islamabad, will be randomly allocated in a 1:1 ratio to receive either skin staples or polypropylene sutures.
The primary outcomes are skin closure time and incidence of surgical site infection within 30 days of surgery. Secondary outcomes include wound dehiscence, postoperative pain, cosmetic scar appearance, patient satisfaction, and duration of hospital stay.
The findings will provide evidence regarding the optimal skin closure technique for elective laparotomy in the Pakistani population.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Skin staples
DeviceDisposable stainless steel skin staples will be used for skin closure following elective laparotomy. Skin closure will be performed according to the standard surgical technique of the Department of General Surgery, Pakistan Institute of Medical Sciences (PIMS), immediately after completion of fascial closure.
Polypropylene skin suture
DeviceSkin closure will be performed using interrupted polypropylene (Prolene) sutures following elective laparotomy according to the standard surgical technique of the Department of General Surgery, Pakistan Institute of Medical Sciences (PIMS).
Treatment groups
Trial outcomes
Primary outcomes
Surgical site infection
SSI occurring within 30 postoperative days based on CDC clinical criteria with wound culture where indicated.
Secondary outcomes
Skin closure time
Measured in seconds from the first skin puncture until completion of skin closure.
Wound Dehiscence
Giving way of the skin closure leading to exposure of subcutaneous tissues.
Post-operative pain
Pain scored on verbal descriptor scale from 1 to 10
Scar appearance
Visual description of scar on analogue scsle by subjective assessment(1-10)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.